DAILY PILL · NO INJECTION · GLP-1
Foundayo®
Orforglipron 0.8 mg – 17.2 mg Tablet
11%
avg. body weight lost in trials
Foundayo is a non-peptide, oral GLP-1 receptor agonist — meaning it works on the same hunger and metabolism pathways as injectable GLP-1s, but as a simple daily pill with no food or water restrictions required.
How It Works
Foundayo is a non-peptide, oral GLP-1 receptor agonist — meaning it works on the same hunger and metabolism pathways as injectable GLP-1s, but as a simple daily pill with no food or water restrictions required.
Key Advantage
Unlike Oral Wegovy, Foundayo can be taken with or without food and with any beverage — making it the most flexible oral GLP-1 option currently available. Ideal for patients whose lifestyle makes the strict Oral Wegovy requirements difficult.
Common Side Effects
Nausea, diarrhea, vomiting, and constipation — similar to other GLP-1 medications, typically mild and improving over time.
Who Should Avoid
Personal or family history of MTC or MEN2 Syndrome. Pregnancy or breastfeeding. Your provider will review your full medical history to confirm eligibility.
This information is for educational purposes only and does not replace medical advice from your physician. Individual results vary. Always discuss side effects, contraindications, and treatment options during your consultation.